November 6, 2025
Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
New Book by WSI Founder Shows How AI Is Rewriting the Rules for Business SEO
Neutral
EIN Presswire
November 6, 2025
There’s A New Livery in Town: Air Canada Reveals Special Livery in Collaboration with Disney’s “Zootopia 2”
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
ADVISORY: Royal Canadian Legion to host Canada’s 2025 National Remembrance Day Ceremony
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
REALTOR.ca Canada Inc. Appoints Scott Neil as Chief Executive Officer
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Rat Sightings Surge Across Canada as New Data Confirms Rising Activity
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
HPQ CEO Applauds and Comments on Canada’s New Federal Budget and Its Positive Impact on HPQ’s Technology Portfolio
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Applied Systems, Ivans, and EZLynx Honored in 2025 TITAN Business Awards
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Connecting the Lighting Community: Canada Light Expo 2025 Returns with Bigger Opportunities
Neutral
EIN Presswire
November 6, 2025
Notified Boosts News Integrity with CLEAR Identity Verification for GlobeNewswire Press Releases in Canada
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
November 5, 2025
Canadian General Investments: Investment Update - Unaudited
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Village Farms International Welcomes Brian Ellis as Chief Information and Technology Officer
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Brookfield Business Partners Reports Third Quarter 2025 Results
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Immunocore reports third quarter financial results and provides a business update
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire, Inc.
November 6, 2025
Esperion Reports Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire, Inc.